based on a few PMs i've rec'd in this week .. i want to

New Post Public Reply Private Reply Replies (2) Message Board

May 10, 2018 at 1:26 PM 486

based on a few PMs i've rec'd in this week .. i want to show the first 3 MMs' who *factually* reported activity to Finra since this time last year .. May 2017 to April 2018 .. as well as the number of MMs' *participating per month* and *volume by month*

you can clearly see who the PRIMARY/SECONDARY and TERTIARY MMs' are re: IPIX

this is important in understanding the role decoys' play in regards to what l2 *shows* on any given day but mostly as is always the case with an OTC SURVIVOR .. what is revealed over weeks/months and in some cases .. years

that is why i can note which MM .. is usually acting as a decoy on l2 ..

note exactly the volume done per month (which is why you can see these same
Marker Manipulators lying in regards to *avg* daily volume (as was just noted
yesterday via *legal* as being in the 500k range) .. is factually false .. it's closer
to 200k on any given week recently .. but what is really worth noting is who doesn't deviate from the first 3 spots .. each and every month .. you can also observe the fact of *decoys* willing to play the UPSIDE DOWN GAME .. with MMs' (back in 2015 .. running 25 to 29) ..MMs now *reporting* between 9 to 11 for IPIX (13 for May 17 .. CTIX) .. is *actually decreasing*

as i've always noted *volume* tells the tale of where in the cycle NR and CEs *are*

today's volume again comes as no surprise .. they need *volume* to show
the only aspect that matters today is where they close IPIX .. and what gets marked .. as i've noted .. this effort i refer to as resets r possible (resetting trades
via those who do)

most can figure out this will relo UP the 10 and 90 avgs .. but will a price (daily reg sho %) have to be paid?

the other fact that can't be ignored to suit is the %s' posted by only 3 MMs every month .. since May 2017 .. 69% to 87% reveals why the round robining rotation of *volume* reported is well in hand by just 3 MMs CONtinues to ramp upwards

make no mistake an educated retail investor is a colluding entity's worst NITE mare (pun intended)

APRIL 2018 .. IPIX Volume ~ 4,473,436
10 MMs' reporting ..
( ETRF/NITE @ 27% .. CDEL @ 20% ) .. total = 75.16% of *volume*
( ARCA .. OTCX .. CSTI @ 9% .. 8% and 4% )
( CANT .. LAFC .. PUMA .. STXG all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 
 
IPIX	Innovation Pharma	4,473,436	4,078,577	17,073,621	ETRF	G1 EXECUTION SVCsETRF, LLC	1,240,454	1	27.73% 
 
IPIX	Innovation Pharma	4,473,436	4,078,577	17,073,621	NITE	VIRTU AMERICAS LLC	1,216,167	2	27.19% 
 
IPIX	Innovation Pharma	4,473,436	4,078,577	17,073,621	CDEL	CITADEL SECURITIES LLC	905,353	3	20.24%

MARCH 2018 .. IPIX Volume ~ 4,078,577
11 MMs' reporting
( ETRF/CDEL/NITE @ 30% ..24% .. 22% ) .. total = 77.55% of *volume*
( ARCA & CSTI @ 10% and 5% )
( OTCX .. LAFC .. CANT .. VERT .. MAXM .. PUMA all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 IPIX	Innovation Pharma	4,078,577	3,388,387	12,600,185	ETRF	G1 EXECUTION SVCs, LLC	1,247,854	1	30.6% 
 
IPIX	Innovation Pharma	4,078,577	3,388,387	12,600,185	CDEL	CITADEL SECURITIES LLC	1,004,220	2	24.62% 
 
IPIX	Innovation Pharma	4,078,577	3,388,387	12,600,185	NITE	VIRTU AMERICAS LLC	910,681	3	22.33%

FEBRUARY 2018 .. IPIX Volume ~ 3,388,387
10 MMs' reporting ..
( ETRF @ 34% .. NITE & CDEL @ 24% ) .. total = 83.04% of *volume*
( ARCA .. CSTI .. LAFC @ 6% .. 4% and 3% )
( CANT .. VERT .. PUMA .. VNDM all sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 IPIX	Innovation Pharma	3,388,387	5,133,221	8,521,608	ETRF	G1 EXECUTION SVCs, LLC	1,152,418	1	34.01% 
 
IPIX	Innovation Pharma	3,388,387	5,133,221	8,521,608	NITE	VIRTU AMERICAS LLC	838,168	2	24.74% 
 
IPIX	Innovation Pharma	3,388,387	5,133,221	8,521,608	CDEL	CITADEL SECURITIES LLC	822,921	3	24.29%

JANUARY 2018 .. IPIX Volume ~ 5,133,221
9 MMs' reporting ..
( NITE @ 33% .. ETRF @ 25% .. CDEL @ 23% ) .. total = 82.27% of *volume*
( ARCA .. CSTI .. LAFC @ 6% .. 5% .. 2% )
( CANT .. PUMA .. MAXM .. all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 IPIX	Innovation Pharma	5,133,221	8,121,069	5,133,221	NITE	VIRTU AMERICAS LLC	1,721,407	1	33.53% 
 
IPIX	Innovation Pharma	5,133,221	8,121,069	5,133,221	ETRF	G1 EXECUTION SVCs, LLC	1,296,054	2	25.25% 
 
IPIX	Innovation Pharma	5,133,221	8,121,069	5,133,221	CDEL	CITADEL SECURITIES LLC	1,206,032	3	23.49%

DECEMBER 2017 .. IPIX Volume ~ 8,121,069
11 MMs' reporting ..
( NITE @ 35% .. CDEL @ 23% .. ETRF @ 18% ) .. total = 76.89% of *volume*
( ARCA .. CSTI .. LAFC .. CANT @ 8% .. 6% .. 3% .. 2% )
( VERT .. MAXM .. INTL .. PUMA all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 IPIX	Innovation Pharma	8,121,069	4,031,082	62,497,265	NITE	VIRTU AMERICAS LLC	2,886,476	1	35.54% 
 
IPIX	Innovation Pharma	8,121,069	4,031,082	62,497,265	CDEL	CITADEL SECURITIES LLC	1,896,344	2	23.35% 
 
IPIX	Innovation Pharmaceuticals Inc. Common Stock	Other OTC	8,121,069	4,031,082	62,497,265	ETRF	G1 EXECUTION SVCs, LLC	1,461,977	3	18%

NOVEMBER 2017 .. IPIX Volume ~ 4,031,082
11 MMs' reporting ..
( NITE @ 31% .. ETRF @ 25% .. CDEL @ 22% ) = total of 79.71% of *volume*
( VERT/CANT/ARCA/LAFC/CSTI .. @ 6% .. 4% .. 3% .. 3% .. 2% )
( PUMA .. MAXM .. AEXG all sub 1% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 IPIX	Innovation Pharma	4,031,082	3,856,915	54,376,196	NITE	VIRTU AMERICAS LLC	1,283,920	1	31.85% 
 
IPIX	Innovation Pharma	4,031,082	3,856,915	54,376,196	ETRF	G1 EXECUTION SVCs, LLC	1,032,596	2	25.62% 
 
IPIX	Innovation Pharma	4,031,082	3,856,915	54,376,196	CDEL	CITADEL SECURITIES LLC	896,653	3	22.24%

OCTOBER 2017 .. IPIX Volume ~ 3,856,915
11 MMs' reporting ..
( NITE .. ETRF .. CDEL @ 33% .. 27% .. 25% ) .. total = 87.51% of *volume*
( LAFC .. CSTI .. VERT @ 3% .. 3% .. 2% )
( CANT .. STXG .. VNDM .. PUMA .. MAXM all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 IPIX	Innovation Pharma	3,856,915	2,395,379	50,345,114	NITE	VIRTU AMERICAS LLC	1,304,156	1	33.81% 
 
IPIX	Innovation Pharma	3,856,915	2,395,379	50,345,114	ETRF	G1 EXECUTION SVCs, LLC	1,068,898	2	27.71% 
 
IPIX	Innovation Pharma	3,856,915	2,395,379	50,345,114	CDEL	CITADEL SECURITIES LLC	1,002,365	3	25.99%

SEPTEMBER 2017 .. IPIX Volume ~ 2,395,379
9 MMs' reporting ..
( NITE .. ETRF .. CDEL @ 33% .. 25% .. 21% ) .. total = 80.32% of *volume*
( VERT .. CSTI .. CANT @ 12% .. 3% .. 2% )
( LAFC .. ARCA .. PUMA all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 IPIX	Innovation Pharma	2,395,379	3,276,355	46,488,199	NITE	VIRTU AMERICAS LLC	807,293	1	33.7% 
 
IPIX	Innovation Pharmaceuticals Inc. Common Stock	Other OTC	2,395,379	3,276,355	46,488,199	ETRF	G1 EXECUTION SVCs, LLC	603,325	2	25.19% 
 
IPIX	Innovation Pharmaceuticals Inc. Common Stock	Other OTC	2,395,379	3,276,355	46,488,199	CDEL	CITADEL SECURITIES LLC	513,444	3	21.43%

AUGUST 2017 .. IPIX Volume ~ 3,276,355
9 MMs' reporting ..
( NITE .. CDEL .. ETRF @ 33% .. 29% .. 21% ) .. total = 84.14% of *volume*
( VERT @ 9% )
( LAFC .. CANT .. CSTI all @ 2% )
( PUMA .. VNDM @ sub 1% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 IPIX	Innovation Pharma	3,276,355	4,896,207	44,092,820	NITE	VIRTU AMERICAS LLC	1,099,604	1	33.56% 
 
IPIX	Innovation Pharma	3,276,355	4,896,207	44,092,820	CDEL	CITADEL SECURITIES LLC	959,917	2	29.3% 
 
IPIX	Innovation Pharma	3,276,355	4,896,207	44,092,820	ETRF	G1 EXECUTION SVCs, LLC	697,321	3	21.28%

JULY 2017 .. IPIX Volume ~ 4,896,207
10 MMs' reporting ..
( CDEL .. NITE .. ETRF @ 35% .. 31% .. 12% ) .. total = 80.42% of *volume*
( CSTI/CANT @ 6% per .. CANT .. LAFC @ 4% .. 2% )
( ARCA PUMA MAXM all @ sub 1% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 IPIX	Innovation Pharma	4,896,207	6,863,055	40,816,465	CDEL	CITADEL SECURITIES LLC	1,752,747	1	35.8% 
 
IPIX	Innovation Pharma	4,896,207	6,863,055	40,816,465	NITE	VIRTU AMERICAS LLC	1,559,023	2	31.84% 
 
IPIX	Innovation Pharma	4,896,207	6,863,055	40,816,465	ETRF	G1 EXECUTION SVCs, LLC	625,666	3	12.78%

JUNE 2017 (note now IPIX) .. IPIX Volume ~ 6,863,055
11 MMs' reporting ..
( CDEL .. NITE .. ETRF @ 37% .. 30% .. 12% ) .. total = 80.50% of *volume*
( CSTI .. CANT .. LAFC .. @ 8% .. 4% .. 3% )
( ARCA .. MAXM .. PUMA .. VNDM .. MICA all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 IPIX	Innovation Pharma	6,863,055	5,182,012	35,920,258	CDEL	CITADEL SECURITIES LLC	2,569,233	1	37.44% 
 
IPIX	Innovation Pharma	6,863,055	5,182,012	35,920,258	NITE	KCG AMERICAS LLC	2,078,242	2	30.28% 
 
IPIX	Innovation Pharma	6,863,055	5,182,012	35,920,258	ETRF	G1 EXECUTION SVCs, LLC	877,231	3	12.78%

MAY 2017 .. CTIX ( 52 week low *reset* to 63c on 5.10.17 ) Volume ~ 5,182,012
13 MMs' reporting ..
( CDEL .. NITE .. ETRF @ 43% .. 14% .. 11% ) .. total = 69.69% of *volume*
( ARCA & CSTI @ 10% .. CANT @ 5% )
( ARXS .. PUMA .. LAFC .. STXG .. VNDM .. MAXM .. FTBR all @ sub 2% )

Symbol
Issue Name
Market
Tot. Volume (Last Month)
Tot. Volume (2 Months Ago)
Tot. Volume (YTD)
MPID
Market Participant Name
MP Volume
Rank
% Of Total Volume

 CTIX	Cellceutix Corp	5,182,012	6,320,318	29,057,203	CDEL	CITADEL SECURITIES LLC	2,254,605	1	43.51% 
 
CTIX	Cellceutix Corp	5,182,012	6,320,318	29,057,203	NITE	KCG AMERICAS LLC	736,389	2	14.21% 
 
CTIX	Cellceutix Corp	5,182,012	6,320,318	29,057,203	ETRF	G1 EXECUTION SVCs, LLC	620,365	3	11.97%

none of this data is difficult to digest .. but it is time consuming which imo is exactly what NR counts on with *retail*

http://otce.finra.org/MonthlyShareVolume

currently ..

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.355Down -0.007 (-1.93 %)AS OF 1:13:47PM ET 05/10/2018

Last Trade 0.355
Trade Time 1:13:47pm ET

Change -0.007
% Change -1.93%

Bid 0.355
Bid Size 10000

Ask 0.3599
Ask Size 5000

Open 0.369
Day High 0.369
Day Low 0.352
Previous Close
05/09/2018 0.362
52-Week High
12/06/2017 1.17
52-Week Low
05/09/2018 0.35

Price Performance (Last 52 Weeks)
05/09/2018 -45.56%

Volume 433,110
Volume (10 day Average) 281,349
Volume (90 day Average) 217,466

Market Capitalization $52.74M

ETRF 0.355 10,000 13:13
CDEL 0.351 6,500 13:03
LAFC 0.351 2,500 12:58
NITE 0.35 8,845 11:08
CSTI 0.34 100,000 11:07
STXG 0.30 2,500 04/17
VNDM 0.30 2,500 05/09
VERT 0.30 2,500 09:48
CANT 0.14 5,000 08:30
PUMA 0.0001 10,000 08:10
MAXM 0.0001 10,000 09:18
DBOX U 0 04/16
OTCX U 0 09:30

CDEL 0.3599 2,500 13:03
LAFC 0.365 10,000 12:58
CSTI 0.37 2,500 08:30
OTCX 0.375 6,000 10:15
NITE 0.38 8,500 12:57
CANT 0.423 2,500 08:30
PUMA 0.50 2,500 08:10
ETRF 0.52 6,000 12:57
VERT 0.66 1,000 05/08
VNDM 1.00 100 05/09
MAXM 1.95 100 09:18
STXG 2.00 100 10/05
DBOX U 0 04/16

4kids

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASO's FUCASO Shows Robust Results in 2026 Study

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

DKS Facing Class Action Over Stock Slump Allegations

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Quay Shines in 2026 Prescription Sunglasses Lineup

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

AI Memory Growth Pushes Limits at GMIF2026 Summit

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Leo Cancer Care's Upright Radiotherapy Milestone

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Revamping Children's Radiotherapy: Leo Cancer Care's Vision

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Salveo Home Care Faces Class Action Over Labor Violations

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Accuray, Samsung Push Boundaries with Imaging Deal

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Melrose Fire Station Reaches Steel Topping Milestone

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...